Dual mTORC1/mTORC2 inhibitor
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Dual mTORC1/mTORC2 inhibitor, covering 2024-02-13 to 2024-02-13. Get the full timeline:
Most recent: Clinical Trial Update: Hormone Receptor Positive endometrIal Carcinoma Treated by Dual mTORC1/mTORC2 Inhibitor and Anastrozole (VICTORIA) [Phase 1, Phase 2]